Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

NCT03363477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Enoxaparin
DRUG: Clexane

Sponsor

Rovi Pharmaceuticals Laboratories

Collaborators

[object Object]